Yeow Tee Goh

机构：Singapore General Hospital · ORCID：0000-0002-7069-0997

发表论文 225 篇 · 总被引 4046 次 · h-index 27

代表论文

• Asciminib in combination with imatinib, nilotinib, or dasatinib in patients with chronic myeloid leukemia in chronic or accelerated phase: phase 1 study final results (2025 · Leukemia · 被引 13)
• Asciminib demonstrates superior efficacy and safety in newly diagnosed chronic myeloid leukemia in the ASC4FIRST trial (2025 · Blood · 被引 12)
• Asciminib monotherapy in patients with chronic myeloid leukemia in chronic phase without BCR::ABL1T315I treated with at least 2 prior TKIs: Phase 1 final results (2025 · Leukemia · 被引 12)
• Prevention and Management of Thromboembolism in Patients with Paroxysmal Nocturnal Hemoglobinuria in Asia: A Narrative Review (2025 · International Journal of Molecular Sciences · 被引 5)
• Efficacy and safety of momelotinib in Janus kinase inhibitor-experienced Asian patients with myelofibrosis and anemia (2025 · International Journal of Hematology · 被引 2)
• Asciminib (ASC) demonstrates continued improvement in patient-reported outcomes (PROs) vs investigator-selected tyrosine kinase inhibitors (IS-TKIs) in newly diagnosed chronic myeloid leukemia (CML): ASC4FIRST week 96 analysis (2025 · Blood · 被引 1)